Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Most adult chronic hair pullers are women who started in their early teens, often have other mental health issues, and may pull hair due to underlying psychiatric conditions.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Current treatments for alopecia show no significant long-term benefits.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Fullerenes show potential in skin care but need more safety research.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Hair grays due to oxidative stress and fewer functioning melanocytes.

Some breast cancer chemotherapy can cause permanent hair loss.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Tattooing helps treat skin conditions, reconstruct nipple-areola, mark radiation fields, and locate lesions.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Finasteride and minoxidil work best together for hair loss.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

HIV can cause unusual and severe skin problems that are hard to treat.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.